Targeting the Gut-Heart Axis Improves Cardiac Remodeling in a Clinical Scale Model of Cardiometabolic Syndrome

IF 8.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS JACC: Basic to Translational Science Pub Date : 2025-01-01 Epub Date: 2024-11-20 DOI:10.1016/j.jacbts.2024.09.004
Florence M. Herisson PhD , Gaston L. Cluzel PhD , Maria Antonia Llopis-Grimalt PhD , Aoife N. O’Donovan PhD , Fatma Koc PhD , Kavita Karnik PhD , Ieva Laurie PhD , Kirstie Canene-Adams PhD , R. Paul Ross PhD , Catherine Stanton PhD , Noel M. Caplice MD, PhD
{"title":"Targeting the Gut-Heart Axis Improves Cardiac Remodeling in a Clinical Scale Model of Cardiometabolic Syndrome","authors":"Florence M. Herisson PhD ,&nbsp;Gaston L. Cluzel PhD ,&nbsp;Maria Antonia Llopis-Grimalt PhD ,&nbsp;Aoife N. O’Donovan PhD ,&nbsp;Fatma Koc PhD ,&nbsp;Kavita Karnik PhD ,&nbsp;Ieva Laurie PhD ,&nbsp;Kirstie Canene-Adams PhD ,&nbsp;R. Paul Ross PhD ,&nbsp;Catherine Stanton PhD ,&nbsp;Noel M. Caplice MD, PhD","doi":"10.1016/j.jacbts.2024.09.004","DOIUrl":null,"url":null,"abstract":"<div><div>Poor diet, gut dysbiosis, and systemic inflammation constitute a gut-heart axis (GHA) that may affect heart failure with preserved ejection fraction. Clinical scale models to interrogate this axis are limited. Here, we show the full extent of the GHA–gut barrier function loss, systemic and microvascular inflammation, and its colocalization with apoptosis (left atrium) and hypertrophy (left ventricle). Gut barrier function primacy in regulating the GHA is supported by a synbiotic intervention that shuts down gut epithelial permeability, markedly decreasing systemic inflammation and, remarkably, cardiac structural changes in left heart chambers. These data support a new paradigm for targeting heart failure with preserved ejection fraction via the GHA.</div></div>","PeriodicalId":14831,"journal":{"name":"JACC: Basic to Translational Science","volume":"10 1","pages":"Pages 1-15"},"PeriodicalIF":8.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Basic to Translational Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452302X24003267","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/20 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Poor diet, gut dysbiosis, and systemic inflammation constitute a gut-heart axis (GHA) that may affect heart failure with preserved ejection fraction. Clinical scale models to interrogate this axis are limited. Here, we show the full extent of the GHA–gut barrier function loss, systemic and microvascular inflammation, and its colocalization with apoptosis (left atrium) and hypertrophy (left ventricle). Gut barrier function primacy in regulating the GHA is supported by a synbiotic intervention that shuts down gut epithelial permeability, markedly decreasing systemic inflammation and, remarkably, cardiac structural changes in left heart chambers. These data support a new paradigm for targeting heart failure with preserved ejection fraction via the GHA.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在心脏代谢综合征的临床模型中,靶向肠心轴改善心脏重塑
不良饮食、肠道生态失调和全身炎症构成肠心轴(GHA),可能影响射血分数保留的心力衰竭。临床模型来询问这个轴是有限的。在这里,我们展示了ga -肠屏障功能丧失、全身和微血管炎症的全部程度,以及它与细胞凋亡(左心房)和肥厚(左心室)的共定位。肠道屏障功能在调节GHA中的首要作用得到了一种合成干预的支持,这种干预可以关闭肠道上皮的渗透性,显著减少全身炎症,并显著减少左心室的心脏结构变化。这些数据支持通过GHA保留射血分数靶向心力衰竭的新范式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JACC: Basic to Translational Science
JACC: Basic to Translational Science CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
14.20
自引率
1.00%
发文量
161
审稿时长
16 weeks
期刊介绍: JACC: Basic to Translational Science is an open access journal that is part of the renowned Journal of the American College of Cardiology (JACC). It focuses on advancing the field of Translational Cardiovascular Medicine and aims to accelerate the translation of new scientific discoveries into therapies that improve outcomes for patients with or at risk for Cardiovascular Disease. The journal covers thematic areas such as pre-clinical research, clinical trials, personalized medicine, novel drugs, devices, and biologics, proteomics, genomics, and metabolomics, as well as early phase clinical trial methodology.
期刊最新文献
Stress-Induced Down-Regulation of CPEB4 Disrupts Sodium Channel Regulation and Myocardial Excitability Methylated PIH1D1 as a Circulating Biomarker for Anthracycline-Related Cardiac Remodeling Unmasking Hormonal Mechanisms of Hypertension in Obesity GPT2-mediated Glutamate to α-Ketoglutaric Acid Conversion in Cardiac Fibroblast Promotes Fibrosis eNOS Uncoupling-ER Stress-Mitochondrial Dysfunction Axis in the Development of Pulmonary Hypertension
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1